SEC Info - Alexandra Global Master Fund Ltd, et al. - ‘SC 13G’ on 12/20/05 re: Cti Biopharma Corp

SEC Info℠

Home

Help

Please Sign In

Alexandra Global Master Fund Ltd, et al. – ‘SC 13G’ on 12/20/05 re: Cti Biopharma Corp

On: Tuesday, 12/20/05, at 10:56am ET · Accession #: 950123-5-14972 · File #: 5-48459

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/20/05  Alexandra Global Master Fund Ltd  SC 13G                 2:17K  Cti Biopharma Corp                RR Donnelley/FA
          Alexandra Investment Management LLC
          Dimitri Sogoloff
          Mikhail A Filimonov

Statement of Beneficial Ownership — Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Beneficial Ownership                      9     34K 
 2: EX-99.I     Joint Filing Agreement                                 1      7K

SC 13G — Statement of Beneficial Ownership
Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Address of Issuer's Principal Executive Offices: Address of Principal Business Office: Alexandra Certification: Identification and Classification of Members of the Group: Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company: Name of Issuer: Names of Persons Filing: Notice of Dissolution of Group: Ownership: Ownership of Five Percent or Less of a Class: Ownership of More Than Five Percent on Behalf of Another Person: Place of Organization or Citizenship: This Schedule is filed pursuant to Rule 13d-1(c) by Alexandra, Management, Filimonov and Sogoloff Title of Class of Securities:
1	1st Page - Filing Submission
6	Item 1(a). Name of Issuer:
"	Item 1(b). Address of Issuer's Principal Executive Offices:
"	Item 2(a). Names of Persons Filing:
"	Item 2(b). Address of Principal Business Office:
"	Item 2(c). Place of Organization or Citizenship:
"	Item 2(d). Title of Class of Securities:
"	Item 3. This Schedule is filed pursuant to Rule 13d-1(c) by Alexandra, Management, Filimonov and Sogoloff
"	Item 4. Ownership:
"	Alexandra
7	Item 5. Ownership of Five Percent or Less of a Class:
"	Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
"	Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company:
"	Item 8. Identification and Classification of Members of the Group:
"	Item 9. Notice of Dissolution of Group:
8	Item 10. Certification:

SC 13G 1st Page of 9 TOC ↑Top Previous Next ↓Bottom Just 1st
 
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 1 OF 10 PAGES

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 (AMENDMENT NO. )*
            --

 Cell Therapeutics, Inc.
(Name of Issuer)

Common Stock, no par value
(Title of Class of Securities)

 150934107
(CUSIP Number)

November 1, 2005
 (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule 
is filed:                                                                       

[ ]  Rule 13d-1(b)                                                              
[X]  Rule 13d-1(c)                                                              
[ ]  Rule 13d-1(d)                                                              

*The remainder of this cover page shall be filled out for a reporting person's  
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter           
disclosures provided in a prior cover page.                                     

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of   
1934 ("Act") or otherwise subject to the liabilities of that section of the Act 
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

 -1-

SC 13G 2nd Page of 9 TOC 1st Previous Next ↓Bottom Just 2nd
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 2 OF 10 PAGES

- ------------------------------------------------------------------------- - 
1   NAME OF REPORTING PERSON                                            
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)       

Alexandra Global Master Fund Ltd.             
(No I.R.S. ID Number)                         

------------------------------------------------------------------------- -     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (A)[ ]            
                                                       (B)[ ] (See Item 6)

------------------------------------------------------------------------- -     
3   SEC USE ONLY                                                        

------------------------------------------------------------------------- -     
4   CITIZENSHIP OR PLACE OF ORGANIZATION                                

British Virgin Islands                        
------------------------------------------------------------------------- -     
NUMBER OF          5  SOLE VOTING POWER                             
SHARES                                                            
BENEFICIALLY                     -0-                                    
   OWNED BY         ---------------------------------------------------- -
EACH             6  SHARED VOTING POWER                         
REPORTING                                                           
PERSON               3,803,727 shares of Common Stock (See Item 4)
     WITH:          ---------------------------------------------------- -
7  SOLE DISPOSITIVE POWER     

 -0-
                    ---------------------------------------------------- -
8  SHARED DISPOSITIVE POWER   

                     3,803,727 shares of Common Stock (See Item 4)
------------------------------------------------------------------------- -     
9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    

3,803,727 shares of Common Stock (See Item 4) 
------------------------------------------------------------------------- -     
10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES           
     CERTAIN SHARES (SEE INSTRUCTIONS)                         [ ]

------------------------------------------------------------------------- -     
11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)               

5.0% (See Item 4)                             
------------------------------------------------------------------------- -     
12      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                     

CO                                            
------------------------------------------------------------------------- -     

-2- 

SC 13G 3rd Page of 9 TOC 1st Previous Next ↓Bottom Just 3rd
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 3 OF 10 PAGES

------------------------------------------------------------------------- -     
1   NAME OF REPORTING PERSON                                            
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)       

Alexandra Investment Management, LLC          
13-4092583                                    
------------------------------------------------------------------------- -     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (A)[ ]            
                                                       (B)[ ] (See Item 6)

------------------------------------------------------------------------- -     
3   SEC USE ONLY                                                        

------------------------------------------------------------------------- -     
4   CITIZENSHIP OR PLACE OF ORGANIZATION                                

Delaware                                      
------------------------------------------------------------------------- -     
NUMBER OF          5  SOLE VOTING POWER                             
SHARES                                                            
BENEFICIALLY                     -0-                                    
   OWNED BY         ---------------------------------------------------- -
EACH             6  SHARED VOTING POWER                         
REPORTING                                                           
 PERSON                3,803,727 shares of Common Stock (See Item 4)
     WITH:          ---------------------------------------------------- -
7  SOLE DISPOSITIVE POWER     

-0-   
                    ---------------------------------------------------- -
8  SHARED DISPOSITIVE POWER   

                     3,803,727 shares of Common Stock (See Item 4)
------------------------------------------------------------------------- -     
9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    

 3,803,727 shares of Common Stock (See Item 4)
------------------------------------------------------------------------- -     
10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES           
     CERTAIN SHARES (SEE INSTRUCTIONS)                         [ ]

------------------------------------------------------------------------- -     
11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)               

5.0%(See Item 4)                              
------------------------------------------------------------------------- -     
12      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                     

OO                                            
------------------------------------------------------------------------- -     

-3- 

SC 13G 4th Page of 9 TOC 1st Previous Next ↓Bottom Just 4th
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 4 OF 10 PAGES

------------------------------------------------------------------------- -     
1   NAME OF REPORTING PERSON                                            
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)       

Mikhail A. Filimonov                          
------------------------------------------------------------------------- -     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (A)[ ]            
                                                       (B)[ ] (See Item 6)

------------------------------------------------------------------------- -     
3   SEC USE ONLY                                                        

------------------------------------------------------------------------- -     
4   CITIZENSHIP OR PLACE OF ORGANIZATION                                

U.S.                                          
------------------------------------------------------------------------- -     
NUMBER OF          5  SOLE VOTING POWER                             
SHARES                                                            
BENEFICIALLY                     -0-                                    
   OWNED BY         ---------------------------------------------------- -
EACH             6  SHARED VOTING POWER                         
REPORTING                                                           
PERSON               3,803,727 shares of Common Stock (See Item 4)
     WITH:          ---------------------------------------------------- -
7  SOLE DISPOSITIVE POWER     

-0-   
                    ---------------------------------------------------- -
8  SHARED DISPOSITIVE POWER   

                     3,803,727 shares of Common Stock (See Item 4)
------------------------------------------------------------------------- -     
9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    

 3,803,727 shares of Common Stock (See Item 4)
------------------------------------------------------------------------- -     
10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES           
     CERTAIN SHARES (SEE INSTRUCTIONS)                         [ ]

------------------------------------------------------------------------- -     
11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)               

5.0% (See Item 4)                             
------------------------------------------------------------------------- -     
12      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                     

IN                                            
------------------------------------------------------------------------- -     

-4- 

SC 13G 5th Page of 9 TOC 1st Previous Next ↓Bottom Just 5th
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 5 OF 10 PAGES

------------------------------------------------------------------------- -     
1   NAME OF REPORTING PERSON                                            
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)       

Dimitri Sogoloff                              
------------------------------------------------------------------------- -     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (A)[ ]            
                                                       (B)[ ] (See Item 6)

------------------------------------------------------------------------- -     
3   SEC USE ONLY                                                        

------------------------------------------------------------------------- -     
4   CITIZENSHIP OR PLACE OF ORGANIZATION                                

U.S.                                          
------------------------------------------------------------------------- -     
NUMBER OF          5  SOLE VOTING POWER                             
SHARES                                                            
BENEFICIALLY                     -0-                                    
   OWNED BY         ---------------------------------------------------- -
EACH             6  SHARED VOTING POWER                         
REPORTING                                                           
PERSON               3,803,727 shares of Common Stock (See Item 4)
     WITH:          ---------------------------------------------------- -
7  SOLE DISPOSITIVE POWER     

-0-   
                    ---------------------------------------------------- -
8  SHARED DISPOSITIVE POWER   

                     3,803,727 shares of Common Stock (See Item 4)
------------------------------------------------------------------------- -     
9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    

 3,803,727 shares of Common Stock (See Item 4)
------------------------------------------------------------------------- -     
10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES           
     CERTAIN SHARES (SEE INSTRUCTIONS)                         [ ]

------------------------------------------------------------------------- -     
11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)               

5.0% (See Item 4)                             
------------------------------------------------------------------------- -     
12      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                     

IN                                            
------------------------------------------------------------------------- -     

-5- 

SC 13G 6th Page of 9 TOC 1st Previous Next ↓Bottom Just 6th
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 6 OF 10 PAGES

Item 1(a).        Name of Issuer:                                               

          Cell Therapeutics, Inc., a Washington corporation (the
"Issuer")                                   

Item 1(b).        Address of Issuer's Principal Executive Offices:              

501 Elliott Avenue West, Suite 400          
Seattle, Washington 98119                   

Item 2(a).        Names of Persons Filing:                                      

   Alexandra Global Master Fund Ltd. ("Alexandra")
       Alexandra Investment Management, LLC ("Management")
Mikhail A. Filimonov ("Filimonov")          
Dimitri Sogoloff ("Sogoloff")               

Item 2(b).        Address of Principal Business Office:                         

          Alexandra - Citco Building, Wickams Cay, P.O. Box 662,
Road Town, Tortola, British Virgin Islands  
        Management - 767 Third Avenue, 39th Floor, New York,
New York 10017                              
       Filimonov - 767 Third Avenue, 39th Floor, New York,
New York 10017                              
      Sogoloff - 767 Third Avenue, 39th Floor, New York,
New York 10017                              

Item 2(c).        Place of Organization or Citizenship:                         

Alexandra - British Virgin Islands          
Management - Delaware                       
Filimonov - U.S.                            
Sogoloff - U.S.                             

Item 2(d).        Title of Class of Securities:                                 

            Common Stock, no par value per share, of the Issuer (the
"Common Stock")                             

Item 2(e).        CUSIP Number: 150934107                                       

Item 3.           This Schedule is filed pursuant to Rule 13d-1(c) by           
 Alexandra, Management, Filimonov and Sogoloff

Item 4.           Ownership:                                                    

(a)     Amount Beneficially Owned:          

Alexandra: 3,803,727 shares*
 Management: 3,803,727 shares*
Filimonov: 3,803,727 shares*
Sogoloff: 3,803,727 shares* 

(b)     Percent of Class:                   

Alexandra: 5.0%*            
Management: 5.0%*           
Filimonov: 5.0%*            
Sogoloff: 5.0%*             

             (Based on 71,850,661 shares of Common Stock
                     outstanding, as of November 4, 2005, as reported by
                     the Issuer in the Issuer's Quarterly Report on Form
                10-Q for the quarter ended September 30, 2005)

-6- 

SC 13G 7th Page of 9 TOC 1st Previous Next ↓Bottom Just 7th
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 7 OF 10 PAGES

       (c)    Number of Shares as to which the Person has:

         (i)     sole power to vote or to direct
the vote      

                   -0-

                     (ii)    shared power to vote or to direct the vote:

                   3,803,727 shares of Common Stock*

                (iii)   sole power to dispose or to direct the
disposition of

                   -0-

                  (iv)    shared power to dispose or to direct the
disposition of

                   3,803,727 shares of Common Stock*

The shares of Common Stock reported as beneficially owned by Alexandra on this  
Schedule are 3,803,727 shares of Common Stock that Alexandra has the right to   
acquire upon conversion of 6.75% Convertible Senior Notes Due 2010 of the       
Issuer.                                                                         

Management serves as investment advisor to Alexandra. By reason of such         
relationship, Management may be deemed to share voting and dispositive power    
over the shares of Common Stock owned by Alexandra. Management disclaims        
beneficial ownership of the shares of Common Stock listed as beneficially owned 
by Alexandra or any other person reporting on this Schedule.                    

Filimonov serves as the Chairman, the Chief Executive Officer, a Managing Member
and the Chief Investment Officer of Management. Sogoloff serves as the          
President, a Managing Member and the Chief Risk Officer of Management. By reason
of such relationships, each of Filimonov and Sogoloff may be deemed to share    
voting and dispositive power over the shares of Common Stock listed as          
beneficially owned by Management. Filimonov and Sogoloff each disclaims         
beneficial ownership of the shares of Common Stock listed as beneficially owned 
by Management or any other person reporting on this Schedule.                   

Item 5.           Ownership of Five Percent or Less of a Class:                 

Not applicable                              

Item 6.           Ownership of More Than Five Percent on Behalf of Another      
Person:                                     

Not applicable                              

Item 7.           Identification and Classification of the Subsidiary which     
         Acquired the Security Being Reported on by the Parent
Holding Company:                            

Not applicable                              

Item 8.           Identification and Classification of Members of the Group:    

Not applicable                              

Item 9.           Notice of Dissolution of Group:                               

-7- 

SC 13G 8th Page of 9 TOC 1st Previous Next ↓Bottom Just 8th
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 8 OF 10 PAGES

Not applicable                              

Item 10.          Certification:                                                

By signing below each signatory certifies that, to the best of its knowledge and
belief, the securities referred to above were not acquired and are not held for 
the purpose of or with the effect of changing or influencing the control of the 
issuer of the securities and were not acquired and are not held in connection   
with or as a participant in any transaction having that purpose or effect.      

Exhibits:                                                                       

  Exhibit I: Joint Filing Agreement, dated as of December 20, 2005, by and
among Alexandra, Management, Filimonov and Sogoloff.                            

-8- 

SC 13G Last Page of 9 TOC 1st Previous Next ↓Bottom Just 9th
SCHEDULE 13G                                                                    
CUSIP NO. 150934107                                           PAGE 9 OF 10 PAGES

 SIGNATURE

By signing below each signatory certifies that, to the best of its    
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the   
control of the issuer of the securities and were not acquired and are not held  
in connection with or as a participant in any transaction having that purpose or
effect.                                                                         

Dated as of December 20, 2005                                                   

ALEXANDRA GLOBAL MASTER FUND LTD.       

 By: ALEXANDRA INVESTMENT MANAGEMENT, LLC,
its Investment Advisor          

By: /s/ Mikhail A. Filimonov    
----------------------------    
Mikhail A. Filimonov            
Title: Managing Member          

ALEXANDRA INVESTMENT MANAGEMENT, LLC    

By: /s/ Mikhail A. Filimonov            
----------------------------            
Mikhail A. Filimonov                    
Title: Managing Member                  

/s/ Mikhail A. Filimonov                
----------------------------            
Mikhail A. Filimonov                    

/s/ Dimitri Sogoloff                    
----------------------------            
Dimitri Sogoloff                        

-9-

SC 13G	1st Page of 9	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13G	2nd Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13G	3rd Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13G	4th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13G	5th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13G	6th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13G	7th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13G	8th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13G	Last Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 9th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13G’ Filing	Date	First	Last	Other Filings

Filed on:	12/20/05	8	9	4
	11/4/05	6		8-K
	11/1/05	1
	9/30/05	6		10-Q, 4, NT 10-Q
				List all Filings

↑Top

Filing Submission 0000950123-05-014972 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Alexandra Global Master Fund Ltd, et al. – ‘SC 13G’ on 12/20/05 re: Cti Biopharma Corp

On: Tuesday, 12/20/05, at 10:56am ET · Accession #: 950123-5-14972 · File #: 5-48459

Previous ‘SC 13G’: ‘SC 13G’ on 12/12/05 · Next: ‘SC 13G’ on 1/18/06 · Latest: ‘SC 13G/A’ on 2/16/10

Statement of Beneficial Ownership — Schedule 13GFiling Table of Contents

SC 13G — Statement of Beneficial OwnershipDocument Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Statement of Beneficial Ownership — Schedule 13G
Filing Table of Contents

SC 13G — Statement of Beneficial Ownership
Document Table of Contents